Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the immune and therapeutic responses of visceral
leishmaniasis patients using N-acetylcysteine (NAC) as an adjuvant therapy to pentavalent
antimony.